Case Report

Accepted on 15 Nov 2024

Case report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression

in Pharmacology of Anti-Cancer Drugs

Hejing Bao
Jiani Zhang
Yuhuan Wang
Zhiting Chen
Xi Luo
Ting Li
Haoran Su
Hehong Bao
Xiaolong Cao
Liping Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448291

Original Research

Accepted on 14 Nov 2024

Role of Anoikis-related gene RAC3 in prognosis, immune microenvironment, and contribution to malignant behavior in vitro and in vivo of bladder urothelial carcinoma

in Pharmacology of Anti-Cancer Drugs

Yusong Zhou
Shiwei Huang
Bing Yang
Jing Tan
Zhun Zhang
Wei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503623

Systematic Review

Accepted on 14 Nov 2024

Interventions for prevention and treatment of trastuzumabinduced cardiotoxicity: an umbrella review of systematic reviews and meta-analyses

in Pharmacology of Anti-Cancer Drugs

Kang Yi
Jianguo Xu
Yafei Xie
Dan Zhou
Mingyue Guo
Yu Qin
Yunfang Wang
Tao You
Jinhui Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1479983

Original Research

Accepted on 14 Nov 2024

Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Linsheng Xu
Bingde Hu
Jingli He
Xin Fu
Na Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1510851

Correction

Published on 14 Nov 2024

Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Hui-Wen Yang
Yan Lan
An Li
Han Wu
Zi-Wei Song
Ai-Ling Wan
Yue Wang
Shi-Bao Li
Shuai Ji
Zhong-Cheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447095

Review

Published on 13 Nov 2024

Natural products: promising therapeutics for targeting regulatory immune cells in the tumor microenvironment

in Pharmacology of Anti-Cancer Drugs

Peng Song
Fei Song
Tingting Shao
Pengjuan Wang
Rongkun Li
Zhe-Sheng Chen
Zhaofang Zhang
Guozhong Xue

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481850

143 views

Original Research

Published on 13 Nov 2024

Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation

in Pharmacology of Anti-Cancer Drugs

Mengdie Ou
Zhicheng Deng
Yonghui Shi
Jianxiong He
Zicong Ye
Ming Guo
Guohua Cheng
Junyan Wu
Li Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1496664

119 views

Original Research

Published on 13 Nov 2024

Integrated analysis of single-cell and bulk transcriptome reveals hypoxia-induced immunosuppressive microenvironment to predict immunotherapy response in high-grade serous ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Qingshan Chen
Yue Zhang
Chao Wang
Hui Ding
Liqun Chi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1450751

199 views

Review

Published on 13 Nov 2024

Anti-breast cancer effects of dairy protein active peptides, dairy products, and dairy protein-based nanoparticles

in Pharmacology of Anti-Cancer Drugs

Deju Zhang
Ying Yuan
Juan Xiong
Qingdong Zeng
Yiming Gan
Kai Jiang
Ni Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486264

Original Research

Published on 13 Nov 2024

Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer

in Pharmacology of Anti-Cancer Drugs

Fengjie Lin
Hanxuan Yang
Zongwei Huang
Ying Li
Qin Ding
Yunbin Ye
Sufang Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464830

Case Report

Published on 13 Nov 2024

Renal microangiopathy induced by lenvatinib in hepatocellular carcinoma: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Cheng Xue
Linlin Cui
Jiaxin Chen
Yang Liu
Yufei Deng
Wenyi Xu
Zhiguo Mao
Jun Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420377

Review

Accepted on 12 Nov 2024

Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application

in Pharmacology of Anti-Cancer Drugs

Murshid Imam
Jiale Ji
Zhijie Zhang
Shunchao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1493188

Original Research

Published on 12 Nov 2024

Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2/SLC7A11/GPX4 signaling pathway

in Pharmacology of Anti-Cancer Drugs

Quancheng Han
Jingle Shi
Yiding Yu
Huajing Yuan
Yonghong Guo
Xiujuan Liu
Yitao Xue
Yan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497733

Original Research

Accepted on 11 Nov 2024

Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Siqi Yang
Zhe Li
Jinshuai Lan
Ming Li
Ya Wu
Liyan Sun
Yue Ding
Tong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486742

Original Research

Accepted on 11 Nov 2024

The Role of Epigenetic Regulation in Pancreatic Ductal Adenocarcinoma Progression and Drug Response: An Integrative Genomic and Pharmacological Prognostic Prediction Model

in Pharmacology of Anti-Cancer Drugs

Kang Fu
Junzhe Su
Yiming Zhou
Xiaotong Chen
Xiao Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498031

Systematic Review

Accepted on 11 Nov 2024

Efficacy and safety of anti-angiogenic drugs combined with chemotherapy in the treatment of platinum-sensitive/resistant ovarian cancer: A meta-analysis with trial sequential analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Haining He
Fei Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1446403

Navigation group

Articles

Case report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression

Role of Anoikis-related gene RAC3 in prognosis, immune microenvironment, and contribution to malignant behavior in vitro and in vivo of bladder urothelial carcinoma

Interventions for prevention and treatment of trastuzumabinduced cardiotoxicity: an umbrella review of systematic reviews and meta-analyses

Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer

Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer

Natural products: promising therapeutics for targeting regulatory immune cells in the tumor microenvironment

Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation

Integrated analysis of single-cell and bulk transcriptome reveals hypoxia-induced immunosuppressive microenvironment to predict immunotherapy response in high-grade serous ovarian cancer

Anti-breast cancer effects of dairy protein active peptides, dairy products, and dairy protein-based nanoparticles

Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer

Renal microangiopathy induced by lenvatinib in hepatocellular carcinoma: a case report and literature review

Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application

Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2/SLC7A11/GPX4 signaling pathway

Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma

The Role of Epigenetic Regulation in Pancreatic Ductal Adenocarcinoma Progression and Drug Response: An Integrative Genomic and Pharmacological Prognostic Prediction Model

Efficacy and safety of anti-angiogenic drugs combined with chemotherapy in the treatment of platinum-sensitive/resistant ovarian cancer: A meta-analysis with trial sequential analysis of randomized controlled trials